Paysign, Inc.
PAYS Nasdaq Services-Business Services, Nec Financials FY2016–FY2025
Last close · Oct 23, 2026
$14.92
1.9%What Paysign, Inc. does
No business description yet.
- Legal name
- Paysign, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 25, 2026
- Accession · CIK
- 0001683168-26-002180
0001496443
Revenue and margins
Paysign, Inc. had $82.0M of revenue in fiscal 2025, up 40.5% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 17.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $51.2M in fiscal 2025, 62.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Paysign, Inc. returned $0.4M to shareholders in fiscal 2025, 1% of free cash flow. The diluted share count rose 7.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Paysign, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $7.4M | $89.9M | $109M | $122M | $165M |
| Debt incl. finance leases | — | — | — | $0.0M | $8.0M |
| Net debt / EBITDA | — | — | — | −17.4x | −10.0x |
| Debt / equity | — | — | — | 0.0x | 0.2x |
| Current ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Total assets | $84.1M | $108M | $147M | $179M | $276M |
| Total liabilities | $71.1M | $92.0M | $122M | $149M | $228M |
| Shareholders' equity | $13.0M | $16.3M | $24.5M | $30.4M | $48.5M |
| Net debt (− = net cash) | — | — | — | −$122M | −$157M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✓ | — | — | — | — | — | — | — | ✕ |
| Current ratio rose | — | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ |
| Revenue rose relative to assets | — | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ | ✕ |
| F-score | — / 3 | 6 / 9 | 5 / 8 | 6 / 8 | 3 / 8 | 4 / 8 | 6 / 8 | 4 / 8 | 6 / 8 | 6 / 9 |
| Accruals ratio | −20.2% | −31.3% | −47.4% | −20.6% | −37.8% | −23.6% | −25.3% | −16.6% | −11.8% | −19.7% |
| Altman Z'' | 0.45 | 1.36 | 1.93 | 3.52 | 0.09 | 0.37 | 0.67 | 0.73 | 0.86 | 1.14 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $10.4M | $15.2M | $23.4M | $34.7M | $24.1M | $29.5M | $38.0M | $47.3M | $58.4M | $82.0M |
| Net interest income | — | $0.0M | $0.1M | — | — | — | — | — | — | — |
| Gross profit | $4.5M | $6.7M | $11.4M | $19.2M | $9.3M | $14.7M | $21.0M | $24.1M | $32.2M | $48.7M |
| Operating income | $1.4M | $1.8M | $2.5M | $6.1M | −$8.3M | −$2.7M | $0.3M | −$0.2M | $1.0M | $7.4M |
| Interest expense | $0.1M | $0.0M | — | — | — | — | — | — | — | — |
| Pretax income | $1.3M | $1.8M | $2.6M | $6.5M | −$8.2M | −$2.7M | $1.1M | $2.4M | $4.1M | $10.0M |
| Income tax | $0.0M | $0.0M | $0.0M | −$0.9M | $0.9M | $0.0M | $0.1M | −$4.1M | $0.3M | $2.5M |
| Net income | $1.4M | $1.8M | $2.6M | $7.5M | −$9.1M | −$2.7M | $1.0M | $6.5M | $3.8M | $7.6M |
| Net income to common | — | — | — | — | — | −$2.7M | $1.0M | $6.5M | $3.8M | $7.6M |
| Diluted EPS | $0.03 | $0.04 | $0.05 | $0.14 | −$0.19 | −$0.05 | $0.02 | $0.12 | $0.07 | $0.13 |
| Diluted shares | 0.04B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.06B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $4.2M | $7.2M | $16.0M | $16.7M | $13.8M | $15.2M | $25.3M | $27.6M | $22.9M | $52.5M |
| Capital expenditure | $0.1M | $0.7M | $0.3M | $0.5M | $1.4M | $0.3M | $0.1M | $0.3M | $0.4M | $1.2M |
| Free cash flow | $4.1M | $6.4M | $15.7M | $16.2M | $12.4M | $14.9M | $25.2M | $27.4M | $22.5M | $51.2M |
| Depreciation and amortization | $0.6M | $0.9M | $1.1M | $1.5M | $2.1M | $2.5M | $2.9M | $4.0M | $6.0M | $8.3M |
| Stock-based compensation | $0.1M | $0.3M | $1.4M | $2.5M | $3.0M | $2.3M | $2.3M | $2.9M | $2.6M | $4.3M |
| Share buybacks | — | — | — | — | — | — | $0.0M | $1.1M | $0.5M | $0.4M |
| Dividends and buybacks | — | — | — | — | — | — | $0.0M | $1.1M | $0.5M | $0.4M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $11.6M | $17.2M | $31.7M | $45.6M | $7.8M | $7.4M | $89.9M | $109M | $122M | $165M |
| Total debt | $0.0M | $0.0M | — | — | — | — | — | — | $0.0M | $8.0M |
| Current assets | $12.0M | $17.9M | $33.2M | $47.9M | $58.0M | $74.3M | $97.7M | $129M | $159M | $240M |
| Current liabilities | $11.1M | $15.6M | $27.3M | $34.2M | $50.6M | $67.4M | $88.6M | $119M | $146M | $216M |
| Property and equipment, net | $0.3M | $0.9M | $0.9M | $0.9M | $1.8M | $1.6M | $1.3M | $1.1M | $1.2M | $1.9M |
| Goodwill | — | — | — | — | — | — | — | — | $0.0M | $4.5M |
| Intangible assets | $1.6M | $1.6M | $2.1M | $3.8M | $3.7M | $4.1M | $5.7M | $8.8M | $12.2M | $22.3M |
| Total assets | $13.9M | $20.4M | $36.2M | $53.5M | $67.8M | $84.1M | $108M | $147M | $179M | $276M |
| Total liabilities | $11.2M | $15.6M | $27.3M | $34.2M | $54.6M | $71.1M | $92.0M | $122M | $149M | $228M |
| Preferred stock | — | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $2.9M | $5.0M | $9.1M | $19.3M | $13.2M | $13.0M | $16.3M | $24.5M | $30.4M | $48.5M |
| Margins | ||||||||||
| Gross margin | 43.6% | 44.0% | 48.7% | 55.5% | 38.6% | 49.9% | 55.1% | 51.1% | 55.1% | 59.4% |
| Operating margin | 13.0% | 11.6% | 10.6% | 17.6% | −34.6% | −9.3% | 0.9% | −0.4% | 1.7% | 9.0% |
| EBITDA margin | 18.5% | 17.4% | 15.2% | 21.9% | −25.8% | −0.8% | 8.6% | 8.2% | 12.0% | 19.1% |
| Net margin | 13.4% | 11.8% | 11.0% | 21.5% | −37.9% | −9.2% | 2.7% | 13.7% | 6.5% | 9.2% |
| FCF margin | 39.3% | 42.3% | 67.2% | 46.9% | 51.4% | 50.6% | 66.3% | 57.9% | 38.6% | 62.5% |
| Net interest share of revenue | — | 0.0% | 0.6% | — | — | — | — | — | — | — |
| Returns | ||||||||||
| Return on capital employed | 49.9% | 36.5% | 27.8% | 31.6% | −48.3% | −16.4% | 1.8% | −0.6% | 3.1% | 12.3% |
| Return on equity | 48.4% | 45.2% | 36.6% | 52.5% | −56.2% | −20.8% | 7.0% | 31.7% | 13.9% | 19.1% |
| Return on assets | 10.1% | 10.5% | 9.1% | 16.6% | −15.1% | −3.6% | 1.1% | 5.1% | 2.3% | 3.3% |
| Return on tangible equity | 104.4% | 52.7% | 37.1% | 48.1% | −95.9% | −30.6% | 9.7% | 41.2% | 21.0% | 34.9% |
| Growth | ||||||||||
| Revenue growth | — | 46.2% | 53.8% | 48.0% | −30.4% | 22.2% | 29.1% | 24.3% | 23.5% | 40.5% |
| Net income growth | — | 27.9% | 44.5% | 188.0% | −222.6% | — | — | 528.4% | −40.9% | 97.9% |
| EPS growth | — | 33.3% | 25.0% | 180.0% | −235.7% | — | — | 500.0% | −41.7% | 85.7% |
| FCF growth | — | 57.4% | 144.2% | 3.2% | −23.7% | 20.2% | 69.2% | 8.5% | −17.7% | 127.6% |
| Share count change | — | 9.5% | 8.2% | 4.9% | −9.7% | 3.5% | 3.8% | 2.3% | 2.6% | 7.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | −6.0x | −6.5x | — | — | — | — | — | — | −17.4x | −10.0x |
| Debt / equity | 0.0x | 0.0x | — | — | — | — | — | — | 0.0x | 0.2x |
| Interest coverage | 17.6x | 55.9x | — | — | — | — | — | — | — | — |
| Current ratio | 1.1x | 1.2x | 1.2x | 1.4x | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.1x | 1.2x | 1.2x | 1.4x | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.1% | 4.6% | 1.1% | 1.3% | 5.7% | 1.1% | 0.3% | 0.6% | 0.7% | 1.5% |
| Stock comp / revenue | 0.9% | 2.0% | 5.8% | 7.3% | 12.3% | 7.7% | 6.0% | 6.0% | 4.5% | 5.2% |
| Payouts / FCF | — | — | — | — | — | — | 0.0% | 4.1% | 2.2% | 0.7% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 6.0 | 5.0 | 6.0 | 3.0 | 4.0 | 6.0 | 4.0 | 6.0 | 6.0 |
| Altman Z'' | 0.4 | 1.4 | 1.9 | 3.5 | 0.1 | 0.4 | 0.7 | 0.7 | 0.9 | 1.1 |
| Accruals ratio | −20.2% | −31.3% | −47.4% | −20.6% | −37.8% | −23.6% | −25.3% | −16.6% | −11.8% | −19.7% |
Source: SEC EDGAR XBRL filings (CIK 0001496443). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
